Table of Contents:
Please find the current state of play hereunder:
Supported questionnaires/tabs per Type of Action
| JU | Program | ToA | Questionnaires supported | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Summary for publication | Deliverables | Milestones | Critical risks | Publi-cations | Dissemination and communication activities | Patents (IPR) | Innovation | SME Impact | Infra-structure | Gender | Energy | Financial support for 3rd parties | ABS Regulation | Science with and for society | Second-ments | Resear- | Open data | Network-wide training activities | Specific question- naire | |||
| AGRIP | AGRI-MULTI-IM/TC |  | | | | |||||||||||||||||
| AMIF | AMIF-AG | | | | | |||||||||||||||||
| H2020 | BBI-CSA | | | | | | | | | | | | | | | | | ||||
| H2020 | BBI-IA-DEMO/FLAG |
| | | | | | | | | | | | | | | | ||||
| H2020 | BBI-RIA | | | | | | | | | | | | | | | | | ||||
| H2020 | COFUND-EJP /PCP/PPI |
| | | | | | | | | | | | | | | | |||||
| Consumer | CONS-JA | | | | | | | |||||||||||||||
| Consumer | CONS-SGA-GA/OG | | | | | | | |||||||||||||||
| Cosme | COSME-EEN-SGA | | | | | | ||||||||||||||||
| Cosme | COSME-GA/GAE/SGA/SGAE | | | | | | ||||||||||||||||
| CREA2020 | CREA2020-AG | | | | | | ||||||||||||||||
| H2020 | CS2-CSA/IA/RIA |
| | | | | | | | | | | | | | | | |||||
| H2020 | CSA | | | | | | | | | | | | | | | | | |||||
| H2020-NIGHT | CSA | | | | | | | | ||||||||||||||
| H2020 | CSA-LSP | | | | | | | | | | | | | | | | | |||||
| JU | Program | ToA | Summary for publications | Deliverables | Milestones | Critical risks | Publi-cations | Dissemination and communication activities | Patents (IPR) | Innovation | SME Impact | Infra-structure | Gender | Energy | Financial support for 3rd parties | ABS Regulation | Science with and for society | Second-ments | Resear- cher's Declaration | Open data | Network-wide training activities | Specific question- naire |
| H2020 | CSA-LS | | | | | | | | | | | | | | | | | ||||
| H2020 | ECSEL-CSA/IA/RIA | | | | | | | | | | | | | | | | | ||||
| EMFF | EMFF-AG | | | | | | | | | | | | ||||||||||
| H2020 | ERA-NET-Cofund |
| | | | | | | | | | | | | | | | |||||
| EPLUS2020 | EPLUS2020-AG | | | | | | ||||||||||||||||
| H2020 | ERC-ADG/COG | | | | | | | | | | | |||||||||||
| H2020 | ERC-LVG |
| | | | | | | | | | |||||||||||
| H2020 | ERC-POC |
| | | | | | | | | | |||||||||||
| H2020 | ERC-POC-LS | | | | | | | | | | | |||||||||||
| H2020 | ERC-STG/SyG | | | | | | | | | | | |||||||||||
| ESTAT | ESTAT-AG | | | | | |||||||||||||||||
| H2020 | EuroHPC-IA/RIA/CSA | | | | | | | | | | | | | | | | | ||||
| H2020 | FCH2-CSA/IA/RIA | | | | | | | | | | | | | | | | | ||||
| JU | Program | ToA | Summary for publications | Deliverables | Milestones | Critical risks | Publi-cations | Dissemination and communication activities | Patents (IPR) | Innovation | SME Impact | Infra-structure | Gen der | Energy | Financial support for 3rd parties | ABS Regulation | Science with and for society | Second-ments | Resear- cher's Declaration | Open data | Network-wide training activities | Specific question- naire |
| H2020 | H2020-EEN-SGA | | | | | | | | | | | | | | | | | |||||
| HERCULE III Program | HERCULE-AG/HERCULE-ER-AG | | | | | | | |||||||||||||||
| 3rd Health Program | HP-PC/PJ | | | | | | | | | |||||||||||||
| 3rd Health Program | HP-SGA-OG/PJ | | | | | | | | | |||||||||||||
| H2020 | IA | | | | | | | | | | | | | | | | | |||||
| H2020 | IA-LS | | | | | | | | | | | | | | | | | |||||
| H2020 | IMI2-CSA/IA/RIA | | | | | | | | | | | | | | | | | ||||
| IMCAP | IMCAP-AG | | | | | | ||||||||||||||||
| ISFB | ISFB-AG | | | | | |||||||||||||||||
| ISFP | ISFP-AG | | | | | |||||||||||||||||
| JUST | JUST-AG | | | | | | | | | | ||||||||||||
| JUST | JUST-DRUGS-AG | | | | | |||||||||||||||||
| JUST | JUST-SGA-OG | | | | | | | | ||||||||||||||
| LIFE | LIFE-TA | | | | | | | |||||||||||||||
| H2020 | MSCA-COFUND-DP/FP |
| | | | | | | | | | | | | | | | | ||||
| H2020 | MSCA-IF-EF-CAR/RI/SE/ST | | | | | | | | | | | | | | | | | |||||
| H2020 | MSCA-IF-GF | | | | | | | | | | | | | | | | | |||||
| H2020 | MSCA-ITN-EID/EJD/ETN |
| | | | | | | | | | | | | | | | | ||||
| JU | Program | ToA | Summary for publications | Deliverables | Milestones | Critical risks | Publi-cations | Dissemination and communication activities | Patents (IPR) | Innovation | SME Impact | Infra-structure | Gender | Energy | Financial support for 3rd parties | ABS Regulation | Science with and for society | Second-ments | Resear- cher's Declaration | Open data | Network-wide training activities | Specific question- naire |
| H2020 | MSCA-RISE |
| | | | | | | | | | | | | | | | | ||||
| H2020 | MSCA-SNLS | | | |||||||||||||||||||
| H2020 | PCP/PPI | | | | | | | | | | | | | | | | | |||||
| REC | REC-AG | | | | | | | | | | ||||||||||||
| REC | REC-SGA-OG | | | | | | | | ||||||||||||||
| RFCS | RFCS-AM/PDP/RPJ | | | | | | | | ||||||||||||||
| H2020 | RIA | | | | | | | | | | | | | | | | | |||||
| H2020 | RIA-LS | | | | | | | | | | | | | | | | | |||||
| H2020 | SESAR-CSA/IA/RIA | | | | | | | | | | | | | | | | | ||||
| H2020 | SGA-CSA/RIA | | | | | | | | | | | | | | | | | |||||
| H2020 | Shift2Rail-CSA/IA/RIA | | | | | | | | | | | | | | | | | ||||
| H2020 | Shift2Rail-IA-LS/RIA-LS | | | | | | | | | | | | | | | | | |||||
| H2020 | SME-1 |
| | | | |||||||||||||||||
| H2020 | SME-2 |
| | | | | | | | | | | | | | | | |||||
| H2020 | SME-2b | | | | | | | | | | | | | | | | | |||||
| SRSP | SRSP-AG | | | | | |||||||||||||||||
| UCPM | UCPM-EXT-AG/INT-AG | | | | | | ||||||||||||||||